+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin



In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin



Pathologie-Biologie 43(3): 208-214



The antibacterial in vitro activity of piperacillin and tazobactam (in a concentration ratio of 8/1) was studied in combination with netilmicin or amikacin by a microtiter checkerboard assay against 162 strains of Enterobacteriaceae. These strains were selected for their resistance pattern to beta-lactam antibiotics and their beta-lactamases were characterized by the mean of isoelectric focusing in comparison with reference strains. A comparison of the MICs of piperacillin, alone and in combination, assessed the efficacy of tazobactam as beta-lactamase inhibitor, particularly when a TEM-1 beta-lactamase was produced. When the strains were sensitive to the aminoglycosides (111 netilmicin-sensitive ones and 131 amikacin-sensitive ones), we observed 55% of synergistic effects and 45% of additions with the combinations piperacillin-tazobactam-netilmicin or amikacin. A synergistic effect was usually encountered with P. mirabilis, P. vulgaris, M. morganii and with the strains of E. coli, E. cloacae and S. marcescens which produced a cephalosporinase only. Among the 51 strains that were intermediate or resistant to netilmicin, 8 ones were inhibited by piperacillin-tazobactam-netilmicin at therapeutic levels (3 synergisms, 5 additions). Among the 31 strains that were intermediate or resistant to amikacin, 24 ones (18 synergisms, 6 additions) were inhibited by piperacillin-tazobactam-amikacin at therapeutic concentrations. In most of the cases, the combination of piperacillin-tazobactam with an aminoglycoside enhanced the antibacterial activity of these agents by decreasing the concentrations necessary to inhibit the strains.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043358997

Download citation: RISBibTeXText

PMID: 7675548


Related references

Antibacterial in vitro activity of piperacillin-tazobactam in combination with netilmicin or amikacin against amoxicillin-resistant strains of Enterobacteriaceae. Pathologie Biologie 43(3): 208-214, 1995

In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae. Pathologie-Biologie 39(5): 374-378, 1991

In vitro activity of netilmicin piperacillin and amikacin against gentamicin tobramycin and carbenicillin resistant gram negative bacteria. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT A73, 1984

Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae. ChemoTherapy 26(6): 409-417, 1980

In vitro synergistic activity of piperacillin combined with tazobactam against beta lactam resistant strains of enterobacteriaceae. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 117, 1991

In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve. Pathologie-Biologie 39(5): 367-373, 1991

Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses. Antimicrobial Agents and ChemoTherapy 48(5): 1688-1698, 2004

A three-dimensional model to study a combination of three antibiotics in vitro. Application to the bactericidal activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria according to their beta-lactam resistance patterns. Pathologie Biologie 46(1): 67-72, 1998

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrobial Agents and ChemoTherapy 38(10): 2351-2356, 1994

Inhibition of -lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Journal of Antimicrobial Chemotherapy 25(4): 567-574, 1990

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Journal of Antimicrobial ChemoTherapy 25(4): 567-574, 1990

Activity of piperacillin/tazobactam in combination with amikacin , trovafloxacin , and ciprofloxacin against Pseudomonas aeruginosa. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 289, 1999

Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. Diagnostic Microbiology & Infectious Disease 38(1): 37-41, 2000

Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatric Hematology and Oncology 21(2): 115-123, 2004

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli. Antimicrobial Agents and ChemoTherapy 60(12): 7527-7529, 2016